Statin use and postoperative atrial fibrillation after major noncardiac surgery

Heart Rhythm

Volumn 9, Issue 2, 2012, Pages 163-169

  Bhave, Prashant D ^a   Goldman, L Elizabeth ^b   Vittinghoff, Eric ^c   Maselli, Judith H ^b   Auerbach, Andrew ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atrial fibrillation; Complications; Noncardiac surgery; Outcomes; Statins

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CORRELATION ANALYSIS; DRUG EFFECT; DRUG UTILIZATION; FEMALE; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT;

ADULT; AGED; ATRIAL FIBRILLATION; COHORT STUDIES; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT READMISSION; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84856172561     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2011.09.003     Document Type: Article

References (31)

1. A.S. Go, E.M. Hylek, K.A. Phillips Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study JAMA 285 2001 2370 2375
2. J.P. Mathew, R. Parks, J.S. Savino Multicenter Study of Perioperative Ischemia Research Group Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. JAMA 276 1996 300 306
3. T.O. Stanley, G.B. Mackensen, H.P. Grocott The impact of postoperative atrial fibrillation on neurocognitive outcome after coronary artery bypass graft surgery Anesth Analg 94 2002 290 295 table of contents
4. J. Halonen, P. Halonen, O. Jarvinen Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial JAMA 297 2007 1562 1567
5. K.K. Cheruku, A. Ghani, F. Ahmad Efficacy of nonsteroidal anti-inflammatory medications for prevention of atrial fibrillation following coronary artery bypass graft surgery Prev Cardiol 7 2004 13 18
6. T.T. Issac, H. Dokainish, N.M. Lakkis Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data J Am Coll Cardiol 50 2007 2021 2028
7. R.J. Aviles, D.O. Martin, C. Apperson-Hansen Inflammation as a risk factor for atrial fibrillation Circulation 108 2003 3006 3010
8. M.K. Chung, D.O. Martin, D. Sprecher C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation Circulation 104 2001 2886 2891
9. G. Patti, M. Chello, D. Candura Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study Circulation 114 2006 1455 1461
10. S. Sicouri, B. Gianetti, A.C. Zygmunt, J.M. Cordeiro, C. Antzelevitch Antiarrhythmic effects of simvastatin in canine pulmonary vein sleeve preparations J Am Coll Cardiol 57 2011 986 993
11. P.K. Lindenauer, P. Pekow, K. Wang, B. Gutierrez, E.M. Benjamin Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery JAMA 291 2004 2092 2099
12. O. Schouten, E. Boersma, S.E. Hoeks Fluvastatin and perioperative events in patients undergoing vascular surgery N Engl J Med 361 2009 980 989
13. D. Amar, H. Zhang, P.M. Heerdt, B. Park, M. Fleisher, H.T. Thaler Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein Chest 128 2005 3421 3427
14. R. Averill, N. Goldfield, J.S. Hughes Jr Methodology Overview: 3M Health Information Systems All Patient Refined Diagnosis Related Groups v 20.0 2003 1 69
15. G.J. Stukenborg, D.P. Wagner, F.E. Harrell Jr Present-at-admission diagnoses improved mortality risk adjustment among acute myocardial infarction patients J Clin Epidemiol 60 2007 142 154
16. G.J. Stukenborg, K.L. Kilbridge, D.P. Wagner Present-at-admission diagnoses improve mortality risk adjustment and allow more accurate assessment of the relationship between volume of lung cancer operations and mortality risk Surgery 138 2005 498 507
17. J.S. Hughes, R.F. Averill, N.I. Goldfield Identifying potentially preventable complications using a present on admission indicator Health Care Financ Rev 27 2006 63 82
18. A. Elixhauser, C. Steiner, D.R. Harris, R.M. Coffey Comorbidity measures for use with administrative data Med Care 36 1998 8 27
19. H.Y. Weng, Y.H. Hsueh, L.L. Messam, I. Hertz-Picciotto Methods of covariate selection: directed acyclic graphs and the change-in-estimate procedure Am J Epidemiol 169 2009 1182 1190
20. J.L. Schafer, J. Kang Average causal effects from nonrandomized studies: a practical guide and simulated example Psychol Methods 13 2008 279 313
21. A.D. Auerbach Changing the practice of perioperative cardioprotection: perioperative beta-blockers after POISE (PeriOperative ISchemic Evaluation) Circ Cardiovasc Qual Outcomes 1 2008 58 61
22. P.J. Devereaux, H. Yang, S. Yusuf Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial Lancet 371 2008 1839 1847
23. D. Poldermans Statins and noncardiac surgery: current evidence and practical considerations Cleve Clin J Med 76 2009 S79 S83
24. A. Shiroshita-Takeshita, B.J. Brundel, B. Burstein Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure Cardiovasc Res 74 2007 75 84
25. P.M. Ridker, E. Danielson, F.A. Fonseca Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
26. D.A. Redelmeier, D. Thiruchelvam, N. Daneman Delirium after elective surgery among elderly patients taking statins CMAJ 179 2008 645 652
27. N. Daneman, D. Thiruchelvam, D.A. Redelmeier Statin use and the risk of surgical site infections in elderly patients undergoing elective surgery Arch Surg 144 2009 938 945
28. E.K. Spanakis, T.K. Kourkoumpetis, G. Livanis, A.Y. Peleg, E. Mylonakis Statin therapy and decreased incidence of positive Candida cultures among patients with type 2 diabetes mellitus undergoing gastrointestinal surgery Mayo Clin Proc 85 2010 1073 1079
29. C. Heeschen, C.W. Hamm, U. Laufs, S. Snapinn, M. Bohm, H.D. White Withdrawal of statins increases event rates in patients with acute coronary syndromes Circulation 105 2002 1446 1452
30. D.E. Fry, M.B. Pine, H.S. Jordan, D.C. Hoaglin, B. Jones, R. Meimban The hazards of using administrative data to measure surgical quality Am Surg 72 2006 1031 1037
31. L.G. Glance, T.M. Osler, D.B. Mukamel, A.W. Dick Impact of the present-on-admission indicator on hospital quality measurement: experience with the Agency for Healthcare Research and Quality (AHRQ) inpatient quality indicators Med Care 46 2008 112 119